US Allergan goes tight with €2.7bn euro bond debut
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Corporate Bonds

US Allergan goes tight with €2.7bn euro bond debut

Allergen_Pills_Pharma_23May2017_Fotolia_230x150

Drug company Allergan made its debut in the euro bond market on Tuesday, bringing a multi-tranche trade that has tightened during execution despite bankers off the deal saying initial price thoughts already looked expensive.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article